Neurology
Oscotec/ADEL Receives FDA Clearance for Alzheimer's Treatment IND Application (ADEL-Y01)
Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain. ADEL-Y...
September 15, 2023 | News
IBT and ATLATL Join Forces to Tackle Challenges in Brain Health
Starting out of China, IBT Global is a rising player in Digital Therapeutics (DTx) with an experienced cross-functional team operating at the intersection ...
September 05, 2023 | News
Salvia BioElectronics Treats First Patient with Neuromodulation for Severe Migraine in Australia
The first patient, a 29-year-old woman from Australia who has suffered from debilitating headaches since the age of 14, experienced immediate and...
August 24, 2023 | News
Sunbird Bio Joins Glympse Bio to Advance Protein-Based Diagnostics
Combined company will operate as Sunbird Bio and focus on advancing clinical-stage platforms with demonstrated potential to enhance patient care in A...
August 14, 2023 | News
Neurophth Raises Almost $95M for Gene Therapy Trials in Series C+ Funding
Additionally, several prominent investment firms participated, including CMG-SDIC Capital, Silicon Paradise Asset Management and Yangtze River Industry Fun...
August 14, 2023 | News
First Patient Dosed in TLX101 Brain Cancer Study for Newly Diagnosed Glioblastoma
IPAX-2 (ClinicalTrials.gov Identifier: NCT05450744) is a Phase I dose escalation study to confirm safety profile of TLX101 in combination with externa...
August 08, 2023 | News
World's First Report: Plasmacluster Technology's Potential to Induce Brain Activation
Sharp Corporation conducted collaborative research on its Plasmacluster technology, with Dr. Goichi Hagiwara, Associate Professor, Faculty of Human Sc...
July 27, 2023 | News
Project Matty to Revolutionize Care for Children with Autism and ADHD Through AI
The co-founders' personal journeys fuel their resolve to bridge the gap in traditional treatments. Born out of one mother's determination to help her ADHD-...
July 25, 2023 | News
CRISPR Gene Editing Opens New Treatment Avenues for Alzheimer's
Two new CRISPR-based strategies offer hope for next-generation Alzheimer's treatments. One seeks to dampen the impact of the most common Alzheimer's ris...
July 17, 2023 | News
Zymedi Collaborates with National Heart, Lung, and Blood Institute to Develop ZMA001 mAb for PAH Treatment
The CRADA between Zymedi and the NHLBI will enable the organizations to collaborate together to advance the development of ZMA001. Zymedi will work...
July 03, 2023 | News
Promising Clinical Trial Data for Migraine Treatment: CER-0001, a Ketogenic Investigational Agent
A poster showcasing data from the RELIEF study of CER-0001 (tricaprilin), being investigated for the preventive treatment of migraine, was presented at t...
July 03, 2023 | News
Hong Kong Polytechnic University researchers develop Optoelectronic Graded Neurons
he tiny visual systems of flying insects have inspired researchers of the Hong Kong Polytechnic University (PolyU) to develop Optoelectronic Graded Neurons...
June 28, 2023 | News
Cognigenics' Intranasal CRISPR Delivery Overcomes Blood-Brain Barrier; Promising Therapeutic Breakthrough
Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the pot...
June 23, 2023 | Analysis
Psylo Partners with Daiichi Sankyo for Non-Hallucinogenic Psychiatric Therapies
Biotech start-up, Psylo, announced that it has entered into a Sponsored Research Agreement with global Japanese pharmaceutical company, Daiichi ...
June 23, 2023 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
